Neuro-Oncology Reviews
Volume
27 Number 12
30 April 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 12, 30 April
Arefnezhd R, Chahardehi AM, Asadi A, Shadravan MM, Shariati A,
Rezaee A, Radmanesh M, Nazarian M, Helfi M, Soleimani Meigoli MS,
Motedayyen H, Rezaei-Tazangi F, Tavakoli MR.
The
function of chaperones in the radioresistance of glioblastoma: a
new insight into the current knowledge.
Brain
Tumor Pathol. 2025 Apr 21. doi:
10.1007/s10014-025-00501-7. PMID:
40259161. Review˰ ˍ
Stockwell CA, Thang M, Kram DE, Satterlee AB, Hingtgen S.
Therapeutic approaches for targeting
the pediatric brain tumor microenvironment.
Drug
Deliv Transl Res. 2025 Apr 21. doi:
10.1007/s13346-025-01839-3. PMID:
40257744. Review˰ ˍ
Marwaha AS, Shepard MJ, Karlovits SM, Herbst J, Wegner RE.
Advancements in adaptive MR-guided
radiotherapy for high-grade gliomas.
J
Neurooncol. 2025 Apr 24. doi:
10.1007/s11060-025-05053-6. PMID:
40272746. Editorial. ˍ
Guillen Arguello R, Kameda-Smith MM, Gadgil N, Okcu MF,
Chintagumpala M, Aldave G.
The role of
preoperative chemotherapy in pediatric neuro-oncology: a
single-center experience and a systematic review of the
literature.
J
Neurosurg Pediatr. 2025 Apr 25:1-14. doi:
10.3171/2025.1.PEDS24512. PMID:
40279718. Review˰ ˍ
De Silva MI, Gan HK, Bardy C.
Repurposing
trifluoperazine for glioblastoma treatment.
Trends
Pharmacol Sci. 2025 Apr 28;46(5):392-406. doi:
10.1016/j.tips.2025.03.005. PMID:
40300936. Review. ˍ
Kang E, Suh JK, Kim SD.
Constitutional
Mismatch Repair Deficiency, the Most Aggressive Cancer
Predisposition Syndrome: Clinical Presentation, Surveillance, and
Management.
J
Korean Neurosurg Soc. 2025 Apr 29;68(3):294-304. doi:
10.3340/jkns.2025.0024. PMID:
40289693. Review. ˍ
Ramezani A, Rahnama M, Mahmoudian F, Shirazi F, Ganji M, Bakhshi
S, Khalesi B, Hashemi ZS, Khalili S.
Current
Understanding of the Exosomes and Their Associated Biomolecules in
the Glioblastoma Biology, Clinical Treatment, and Diagnosis.
J
Neuroimmune Pharmacol. 2025 Apr 29;20(1):48. doi:
10.1007/s11481-025-10204-7. PMID:
40299204. Review˰ ˍ
Wagner-Ballon C, Moreira A, Houessinon A, Boone M.
Defining
end-of-life in glioblastoma multiforme: a systematic review.
J
Neurooncol. 2025 Apr 29. doi:
10.1007/s11060-025-05051-8. PMID:
40301239. Review. ˍ
Hoogendijk R, Geurts M, van der Lugt J.
Correlative
Studies In Central Nervous System Tumors Clinical Trials: The
Emerging Role Of Microbiome Research.
Neuro
Oncol. 2025 Apr 30:noaf111. doi:
10.1093/neuonc/noaf111. PMID:
40305456. Editorial. ˍ